Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07118085RecruitingPhase 1
Testing the safety of IMC-003 in healthy postmenopausal women
This study tests the safety of a new medicine called IMC-003. It is for healthy women who have gone through menopause. You may be able to join if you are between 45 and 75 years old and meet certain health criteria.
Chengdu, SichuanAges 45–75 - NCT07119177Recruiting
Long-term effects of gestational diabetes on health
This study looks at how gestational diabetes (high blood sugar during pregnancy) may affect your health over the long term. It involves reviewing your pregnancy records and doing follow-up check-ups to understand changes in your body.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07119801Recruiting
Shock wave therapy for arm stiffness after stroke
This trial tests whether shock wave therapy can help reduce muscle tightness in the wrist and hand after a stroke. It may be an option if you have had one stroke, are between 35 and 65 years old, and still have stiffness that bothers you.
DenizliAges 35–65 - NCT07125079Recruiting
Studying immune cells and a new treatment for ARDS
This study looks at how the immune system responds in people with ARDS (a severe lung injury) and tests a new treatment called PIP-2 in the lab to see if it might help. It aims to better understand lung injury and find new ways to treat it.
Philadelphia, PennsylvaniaAges 21–90 - NCT07124858Recruiting
Fruquintinib for advanced colorectal cancer
This study tracks how well fruquintinib works for people with advanced colorectal cancer that has spread. It aims to find factors that predict better outcomes, using blood and tumor samples.
Poitiers, FranceAges 18 years+ - NCT07119359Recruiting
TB and HIV prevention study for households in Uganda
This study tests whether adding HIV prevention services to routine TB household contact checks can help more people stay healthy. If you or someone you live with has TB, you may be able to join.
KampalaAges 15 years+ - NCT07122700Recruiting
Better tests for fatty liver disease in people with metabolic issues
This study compares new, non-invasive tests to standard liver biopsy for diagnosing fatty liver disease in people with type 2 diabetes or other signs of metabolic syndrome. It aims to see if these simpler tests can replace biopsies.
Miami, FloridaAges 18–75 - NCT07120087Recruiting
Online program to lower breast cancer risk for high-risk women
This trial tests an online program that teaches women at high risk of breast cancer how to lower their risk. If you were part of the MyPeBS study and found to have high risk, this program might help you take steps to protect your health.
LyonAges 40–74 - NCT04435990RecruitingPhase 3
Allergy shots for dust mites in teens and adults
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
Santiago de Compostela, A CoruñaAges 12–65 - NCT04898283RecruitingPhase 3
Allergy shot study for grass and cypress pollen symptoms
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
Valladolid, Castille and LeónAges 12–65 - NCT06966427Recruiting
Using a dosing app for insulin management
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
Petah TikvaAges 6–75 - NCT04723485Recruiting
Study of obsessive-compulsive disorder in youth
This study looks at obsessive-compulsive disorder (OCD) in children and young adults to better understand and document treatment and experiences. It may help researchers learn what supports work best for young people with OCD.
Zurich, Canton of ZurichAges 4–18 - NCT07108712Recruiting
Using brain MRI to detect early white matter disease
This trial studies whether a special type of MRI can find brain white matter changes early. It might help people who have early symptoms or are at risk for diseases affecting the brain's wiring.
CairoAges 18–80 - NCT07114094Recruiting
Developing a tool to safely reduce medications in older adults
This study aims to create and test a tool that helps doctors decide which medications might be safely stopped or reduced for patients aged 60 and older. If you're an older adult visiting a general medicine or family medicine clinic, you may be able to help shape this tool.
Bangalore, KarnatakaAges 60 years+ - NCT07114029Recruiting
Mesh-free prolapse surgery study using vNOTES approach
This trial tests a new surgical method called vNOTES for repairing pelvic organ prolapse without using mesh. It aims to see if this approach improves symptoms and anatomy recovery for women with moderate to severe prolapse.
IstanbulAges 18–75 - NCT07115485RecruitingPhase 2
Study of HLX43 for advanced stomach or junction cancer
This trial tests a new drug called HLX43 (an antibody-drug conjugate targeting PD-L1) for people with advanced stomach or gastroesophageal junction cancer that has progressed after at least one prior treatment. It aims to see if it can shrink tumors and help patients live longer.
BeijingAges 3 weeks–2 months - NCT07113522RecruitingPhase 2
Study of new therapies for Crohn's and colitis
This trial tests new therapies for people with moderate to severe Crohn's disease or ulcerative colitis. It may help if your standard treatments aren't working well enough.
Birmingham, AlabamaAges 18–80 - NCT07106892RecruitingPhase 2
Testing HLX43 for advanced colorectal cancer
This trial tests a new drug, HLX43, that targets a protein called PD-L1 on cancer cells and delivers a chemotherapy-like payload directly to them. It's for people with advanced colorectal cancer that hasn't responded to standard treatments.
BeijingAges 3 weeks–2 months - NCT07110896Recruiting
Can a probiotic reduce stress and sharpen focus in older adults?
This study tests a probiotic supplement called Humiome® Post LB to see if it can help reduce feelings of stress and anxiety and improve memory in adults aged 50-75. You may join if you are generally healthy, have noticed some mild memory slips, and are willing to keep your current diet and routines.
ParisAges 50–75 - NCT07113262RecruitingPhase 3
Study of IBI311 for people with inactive thyroid eye disease
This trial tests a new medication called IBI311 for people whose thyroid eye disease is no longer active but still causes bulging eyes. It aims to see if the drug can reduce eye bulging safely.
Shenyang, LiaoningAges 18–80 - NCT07108088Recruiting
Walking aid study for foot and ankle weakness
This study tests a leg brace (orthosis) called NEUROSWING to see if it helps people with foot drop or other foot and ankle weakness walk faster. It is a real-world study to support coverage by French health insurance.
Hérouville-Saint-ClairAges 18 years+ - NCT07115004RecruitingPhase 3
Testing an injectable drug for von Willebrand disease
This trial tests a new drug called VGA039 that is injected under the skin to prevent bleeding episodes in people with von Willebrand disease. It is for those who bleed frequently and are not currently using regular preventive treatments.
Little Rock, ArkansasAges 12–75 - NCT07113925RecruitingPhase 1
Testing TQB2101 for advanced blood cancers
This trial tests a new drug called TQB2101 for people with advanced blood cancers that haven't improved with standard treatments. The goal is to see if the drug is safe and effective.
Zhengzhou, HenanAges 18–75 - NCT07114874RecruitingPhase 3
A long-term study of a new drug for schizophrenia
This study tests a new medicine called NBI-1117568 for adults with schizophrenia over a longer period of time. Participants will stop their current antipsychotics and take this new drug to see how well it works and how safe it is.
Bryant, ArkansasAges 18–65
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.